هيدروكلوريد التابنتادول
| Kind | API |
|---|---|
| Class | Opioid analgesic — centrally acting mu-agonist / norepinephrine-reuptake inhibitor |
| Synonyms | Tapentadol HCl, Tapentadoli hydrochloridum |
| Common uses / forms | IR and ER tablets; moderate-severe acute pain and chronic/neuropathic pain |
| Properties | Dual mechanism (mu agonism + NRI); single-enantiomer (chiral) fully synthetic molecule; water-soluble; BCS Class I; Schedule II controlled |
| Sourcing origins | India, EU |
| Dominant inbound route | Hormuz |
| Indicative price band | $$$ ($100–1000 / kg) |
| Indicative lead time | long (80–120+ days) |
| Notes | Controlled substance; NO confirmed USP/EP/BP monograph — molecule only genericized recently (post-2021) and pharmacopoeial coverage still developing, so the claimed USP entry was pruned pending verification; originator (Grünenthal) patents lapsed so Indian generic API now available; chiral/single-enantiomer purity is a key spec. |
Open the interactive Data Bank (363 substances) · the full table · Supply Resilience Studio
Share: LinkedIn · X · WhatsApp · Telegram · Email
Cite as: AUPAM Experts' Office, Tapentadol Hydrochloride — sourcing profile (API) — AUPAM Data Bank, retrieved 2026-08-31, https://aupameo.org/datasets/databank/a-tapentadol-hydrochloride.html